. 2013 Nov 22;105(1):126–133. doi: 10.1111/cas.12305

Table 2.

Correlation between clinicopathological variables and phenotypic mucin marker expression in undifferentiated-type adenocarcinoma of stomach

Clinicopathological findings	Phenotypic marker expression in tumor cells
	MUC5AC		MUC6		MUC2		CD10
	+/− n = 52/61	P-value	+/− n = 48/65	P-value	+/− n = 27/86	P-value	+/− n = 23/90	P-value
Mean age, years	65.7/68.3	0.207	65.7/68.2	0.232	67.0/67.2	0.938	71.6/68.7	0.706
Gender
Male (n = 72)	34/38	0.734	28/44	0.306	15/57	0.312	15/57	0.867
Female (n = 41)	18/23	0.734	20/21	0.306	12/29	0.312	8/33	0.867
Depth of invasion
T1 (n = 42)	23/19	0.151	22/20	0.101	13/29	0.176	8/34	0.791
T2–4 (n = 71)	29/42	0.151	26/45	0.101	14/57	0.176	15/56	0.791
Lymphatic invasion
Negative (n = 39)	20/19	0.415	19/20	0.330	10/29	0.752	8/31	0.976
Positive (n = 74)	32/42	0.415	29/45	0.330	17/57	0.752	15/59	0.976
Venous invasion
Negative (n = 54)	28/26	0.234	26/28	0.243	17/37	0.070	10/44	0.643
Positive (n = 59)	24/35	0.234	22/37	0.243	10/49	0.070	13/46	0.643
Mean tumor size, mm	66.4/52.2	0.482	63.3/55.4	0.754	60.4/58.2	0.496	55.1/59.7	0.847
Lymph node metastasis
N0 (n = 50)	25/25	0.449	25/25	0.150	12/38	0.981	8/42	0.306
N1–3 (n = 63)	27/36	0.449	23/40	0.150	15/48	0.981	15/48	0.306
Distant metastasis
M0 (n = 102)	50/52	0.062	45/57	0.349	26/76	0.455	21/81	1.000
M1 (n = 11)	2/9	0.062	3/8	0.349	1/10	0.455	2/9	1.000
Stage
I + II (n = 65)	30/35	0.973	30/35	0.358	16/49	0.834	13/52	0.913
III + IV (n = 48)	22/26	0.973	18/30	0.358	11/37	0.834	10/38	0.913

+, positive; −, negative.